Dhritiman Roy

6PUBLICATIONS
13CO-AUTHORS
AutoimmunityPharmacogenomicsPharmaceutical delivery technologiesToxicology (incl. clinical toxicology)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 16, 2026
Neuroimmune Regulation of NLRP3 Signalling in Parkinson's Disease.

|Jan 09, 2025
In silico design and computational screening of berberine derivatives for potential antidiabetic activity through allosteric activation of the AMPK pathway.

Bibhuti Bhusan Kakoti, James H Zothantluanga, Kangkan Deka

|Sep 24, 2024
Roflumilast-loaded nanostructured lipid carriers attenuate oxidative stress and neuroinflammation in Parkinson's disease model.

Dhritiman Roy, Shivaramakrishnan Balasubramanian, Prajwal P Kunte

|Jan 25, 2024
The identification of c-Abl inhibitors as potential agents for Parkinson's disease: a preliminary in silico approach.

Emdormi Rymbai, Dhritiman Roy, Srikanth Jupudi

|Aug 17, 2023
In-silico screening of Acacia pennata and Bridelia retusa reveals pinocembrin-7-O-β-D-glucopyranoside as a promising β-lactamase inhibitor to combat antibiotic resistance.

Abd Kakhar Umar, Dhritiman Roy, Mohnad Abdalla

|Apr 19, 2023
Phosphodiesterase-4 Inhibition in Parkinson's Disease: Molecular Insights and Therapeutic Potential.

Dhritiman Roy, Shivaramakrishnan Balasubramanian, Praveen Thaggikuppe Krishnamurthy

Pageof 1

Frequent Collaborators

4 joint publications

Emdormi Rymbai

2 joint publications

Shivaramakrishnan Balasubramanian

2 joint publications

James H Zothantluanga

1 joint publications

Praveen Thaggikuppe Krishnamurthy